Kask AM - Search Results

1

MK-801 reverses effects of chronic levodopa on D1 and D2 dopamine agonist-induced rotational behavior.

Boldry RC, Papa SM, Kask AM, Chase TN. Boldry RC, et al. Among authors: kask am. Brain Res. 1995 Sep 18;692(1-2):259-64. doi: 10.1016/0006-8993(95)00690-r. Brain Res. 1995. PMID: 8548312

2

Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration.

Papa SM, Engber TM, Kask AM, Chase TN. Papa SM, et al. Among authors: kask am. Brain Res. 1994 Oct 31;662(1-2):69-74. doi: 10.1016/0006-8993(94)90796-x. Brain Res. 1994. PMID: 7859092

3

Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists.

Anderson JJ, Kask AM, Chase TN. Anderson JJ, et al. Among authors: kask am. Eur J Pharmacol. 1996 Jan 11;295(2-3):163-8. doi: 10.1016/0014-2999(95)00661-3. Eur J Pharmacol. 1996. PMID: 8720580

4

Reversal of levodopa-induced motor fluctuations in experimental parkinsonism by NMDA receptor blockade.

Papa SM, Boldry RC, Engber TM, Kask AM, Chase TN. Papa SM, et al. Among authors: kask am. Brain Res. 1995 Dec 1;701(1-2):13-8. doi: 10.1016/0006-8993(95)00924-3. Brain Res. 1995. PMID: 8925275

5

Physostigmine treatment of progressive supranuclear palsy.

Litvan I, Gomez C, Atack JR, Gillespie M, Kask AM, Mouradian MM, Chase TN. Litvan I, et al. Among authors: kask am. Ann Neurol. 1989 Sep;26(3):404-7. doi: 10.1002/ana.410260318. Ann Neurol. 1989. PMID: 2802540 Clinical Trial.

6

Controlled release levodopa treatment of motor fluctuations in Parkinson's disease.

Juncos JL, Fabbrini G, Mouradian MM, Serrati C, Kask AM, Chase TN. Juncos JL, et al. Among authors: kask am. J Neurol Neurosurg Psychiatry. 1987 Feb;50(2):194-8. doi: 10.1136/jnnp.50.2.194. J Neurol Neurosurg Psychiatry. 1987. PMID: 3572434 Free PMC article.

7

CCK26-33 degrading activity in brain and nonneural tissue: a metalloendopeptidase.

Steardo L, Knight M, Tamminga CA, Barone P, Kask AM, Chase TN. Steardo L, et al. Among authors: kask am. J Neurochem. 1985 Sep;45(3):784-90. doi: 10.1111/j.1471-4159.1985.tb04061.x. J Neurochem. 1985. PMID: 3897456

8

Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistry.

Harro J, Tõnissaar M, Eller M, Kask A, Oreland L. Harro J, et al. Brain Res. 2001 Apr 27;899(1-2):227-39. doi: 10.1016/s0006-8993(01)02256-9. Brain Res. 2001. PMID: 11311884

9

Effects of melanocortin receptor ligands on ethanol intake and opioid peptide levels in alcohol-preferring AA rats.

Ploj K, Roman E, Kask A, Hyytiä P, Schiöth HB, Wikberg JE, Nylander I. Ploj K, et al. Brain Res Bull. 2002 Oct 30;59(2):97-104. doi: 10.1016/s0361-9230(02)00844-4. Brain Res Bull. 2002. PMID: 12379439

10

Chronic infusion of a melanocortin receptor agonist modulates dopamine receptor binding in the rat brain.

Lindblom J, Kask A, Hägg E, Härmark L, Bergström L, Wikberg J. Lindblom J, et al. Pharmacol Res. 2002 Feb;45(2):119-24. doi: 10.1006/phrs.2001.0913. Pharmacol Res. 2002. PMID: 11846623

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters